A detailed history of Israel Englander (Millennium Management LLC) transactions in 89bio, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 381,981 shares of ETNB stock, worth $3.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
381,981
Previous 1,010,352 62.19%
Holding current value
$3.05 Million
Previous $8.09 Million 65.08%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.36 - $9.66 $4.62 Million - $6.07 Million
-628,371 Reduced 62.19%
381,981 $2.83 Million
Q2 2024

Aug 14, 2024

SELL
$7.31 - $10.9 $561,736 - $837,610
-76,845 Reduced 7.07%
1,010,352 $8.09 Million
Q1 2024

May 15, 2024

BUY
$8.13 - $13.77 $4.3 Million - $7.27 Million
528,312 Added 94.53%
1,087,197 $12.7 Million
Q4 2023

Feb 14, 2024

BUY
$6.66 - $16.03 $1.59 Million - $3.83 Million
238,735 Added 74.57%
558,885 $6.24 Million
Q2 2023

Aug 14, 2023

SELL
$14.15 - $22.03 $17.3 Million - $27 Million
-1,223,497 Reduced 79.26%
320,150 $6.07 Million
Q1 2023

May 15, 2023

SELL
$10.48 - $16.94 $131,901 - $213,206
-12,586 Reduced 0.81%
1,543,647 $23.5 Million
Q4 2022

Feb 14, 2023

BUY
$5.52 - $12.73 $3.9 Million - $9 Million
706,686 Added 83.18%
1,556,233 $19.8 Million
Q3 2022

Nov 14, 2022

BUY
$3.02 - $7.0 $2.12 Million - $4.9 Million
700,425 Added 469.7%
849,547 $4.92 Million
Q2 2022

Aug 15, 2022

BUY
$2.09 - $4.02 $169,091 - $325,238
80,905 Added 118.6%
149,122 $480,000
Q1 2022

May 16, 2022

BUY
$3.45 - $14.99 $235,348 - $1.02 Million
68,217 New
68,217 $257,000
Q2 2021

Aug 16, 2021

SELL
$17.42 - $28.0 $1.81 Million - $2.91 Million
-104,013 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$20.22 - $26.73 $195,850 - $258,906
-9,686 Reduced 8.52%
104,013 $2.46 Million
Q4 2020

Feb 16, 2021

SELL
$23.16 - $28.08 $112,187 - $136,019
-4,844 Reduced 4.09%
113,699 $2.77 Million
Q3 2020

Nov 16, 2020

BUY
$24.34 - $38.82 $2.36 Million - $3.76 Million
96,840 Added 446.21%
118,543 $3.04 Million
Q2 2020

Aug 14, 2020

BUY
$19.93 - $31.2 $432,540 - $677,133
21,703 New
21,703 $433,000

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $371M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.